Lance Wilkes Analyst PerformanceAnalyst at Sanford C. BernsteinLance Wilkes is a stock analyst at Sanford C. Bernstein in the healthcare sector, covering 9 publicly traded companies. Over the past year, Lance Wilkes has issued 33 stock ratings, including buy and hold recommendations. While full access to Lance Wilkes' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lance Wilkes' coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings41 Last 8 YearsBuy Recommendations70.00% 28 Buy RatingsCompanies Covered9 Unique Companies Ratings Distribution40RatingsDistribution of strong buy, buy, hold, and sell ratings by Lance Wilkes.RatingPercentageCount Strong Buy0.0%0 ratings Buy70.0%28 ratings Hold30.0%12 ratings Sell0.0%0 ratingsOut of 40 total stock ratings issued by Lance Wilkes at Sanford C. Bernstein, the majority (70.0%) have been Buy recommendations, followed by 30.0% Hold.Best & Worst CallsBest Call0000.0%CNCSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MOHApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE100.0% of companies on NYSE9 companiesLance Wilkes, an analyst at Sanford C. Bernstein, currently covers 9 companies listed on , with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare9 companies100.0%Lance Wilkes of Sanford C. Bernstein specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES9 companies100.0% Lance Wilkes' Ratings History at Sanford C. Bernstein Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAGLAgilon Health9/15/2026Upgrade$92.16$125.00Outperform$0.0000.00% ROICVSCVS Health9/9/2026Reiterated Rating$93.35$112.00Outperform$0.0000.00% ROIUNHUnitedHealth Group9/2/2026Reiterated Rating$399.62Outperform$0.0000.00% ROICNCCentene8/3/2026Reiterated Rating$62.23$79.00Outperform$0.0000.00% ROIUNHUnitedHealth Group7/21/2026Reiterated Rating$430.47Outperform$0.0000.00% ROIELVElevance Health7/16/2026Set Price Target$372.20$488.00$0.0000.00% ROIHCAHCA Healthcare7/15/2026Reiterated Rating$372.91Market Perform$0.0000.00% ROICICigna Group7/9/2026Boost Price Target$289.89$381.00Outperform$0.0000.00% ROICICigna Group7/8/2026Boost Price Target$289.89$381.00Outperform$0.0000.00% ROIELVElevance Health7/2/2026Boost Price Target$415.51$482.00Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. UNHUnitedHealth Group6/23/2026Reiterated Rating$408.18Outperform$0.0000.00% ROIHCAHCA Healthcare6/4/2026Lower Price Target$368.31$413.00Market Perform$0.0000.00% ROIHCAHCA Healthcare6/4/2026Lower Price Target$364.00$413.00Market Perform$0.0000.00% ROIUNHUnitedHealth Group5/27/2026Boost Price Target$377.48$492.00Outperform$0.0000.00% ROICVSCVS Health5/12/2026Boost Price Target$92.26$106.00Outperform$0.0000.00% ROICICigna Group5/5/2026Boost Price Target$279.53$371.00Outperform$0.0000.00% ROIUNHUnitedHealth Group4/7/2026Boost Price Target$302.77$411.00Outperform$0.0000.00% ROICVSCVS Health3/12/2026Upgrade$75.74$94.00Outperform$0.0000.00% ROICICigna Group3/12/2026Upgrade$260.79$358.00Outperform$0.0000.00% ROICICigna Group3/4/2026Reiterated Rating$283.58Market Perform$0.0000.00% ROIUNHUnitedHealth Group1/28/2026Reiterated Rating$282.32Outperform$0.0000.00% ROIMOHMolina Healthcare1/6/2026Reiterated Rating$183.27$224.00Outperform$0.0000.00% ROIHUMHumana1/6/2026Reiterated Rating$276.16$344.00Outperform$0.0000.00% ROICVSCVS Health1/6/2026Reiterated Rating$80.32$91.00Market Perform$0.0000.00% ROICICigna Group1/6/2026Reiterated Rating$283.91$307.00Market Perform$0.0000.00% ROICNCCentene1/6/2026Reiterated Rating$45.20$59.00Outperform$0.0000.00% ROICVSCVS Health12/12/2025Boost Price Target$80.76$87.00Market Perform$0.0000.00% ROICVSCVS Health12/4/2025Boost Price Target$76.75$86.00Market Perform$0.0000.00% ROICNCCentene11/21/2025Reiterated Rating$34.85$45.00Outperform$0.0000.00% ROICICigna Group11/12/2025Lower Price Target$267.82$294.00Market Perform$0.0000.00% ROIUNHUnitedHealth Group10/30/2025Boost Price Target$345.20$440.00Outperform$0.0000.00% ROICNCCentene10/29/2025Reiterated Rating$35.68Outperform$0.0000.00% ROIUNHUnitedHealth Group10/8/2025Boost Price Target$372.72$433.00Outperform$0.0000.00% ROICVSCVS Health9/5/2025Boost Price Target$73.83$77.00Market Perform$00.0000.00% ROIUNHUnitedHealth Group9/5/2025Boost Price Target$314.04$379.00Outperform$000.0000.00% ROIMOHMolina Healthcare9/5/2025Lower Price Target$172.79$220.00Outperform$000.0000.00% ROIHUMHumana9/5/2025Boost Price Target$310.95$341.00Outperform$000.0000.00% ROICNCCentene9/5/2025Lower Price Target$28.65$36.00Outperform$00.0000.00% ROIAGLAgilon Health8/20/2025Reiterated Rating$31.13$35.00Market Perform$00.0000.00% ROIMOHMolina Healthcare4/22/2025Initiated Coverage$301.66$414.00Outperform$000.0000.00% ROIMILLIONAIRE MASTERCLASS INVITE: Altucher (Ad)James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.Watch James Altucher's free masterclass before September 25 Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuhoStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
